R.J. Knox
Enact Pharma Plc
Salisbury
United Kingdom
Name/email consistency: medium
- Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Knox, R.J., Jenkins, T.C., Hobbs, S.M., Chen, S., Melton, R.G., Burke, P.J. Cancer Res. (2000)